Potential Substitute for Wheelchairs Gains FDA Approval
The U.S. Food and Drug Administration recently approved the home use of the ReWalk robot exoskeleton. The device acts as a “wearable robot”, by assisting paraplegics to walk upright and be mobile. According to Allan Kozlowski, PhD, Assistant Professor of Rehabilitation Medicine at the Icahn School of Medicine at Mount Sinai, and head of the Exoskeleton-Assisted Walking Program at The Mount Sinai Hospital, patients using ReWalk experience better circulation, increased oxygen intake, pain relief, improved bowel function, and increased psychological benefits that come from being able to stand upright and look people in the eye.
-Dr. Allan Kozlowski, Assistant Professor, Rehabilitation Medicine, Icahn School of Medicine at Mount Sinai